The focal point of clinical studies linking increased BBB permeability with MDD pathophysiology has been assessment of differences in cerebrospinal fluid (CSF)‐to‐serum ratios of various molecules, such as albumin. The gene discussed is ALB; the disease is major depressive disorder.